Age affects efficacy of immunotherapy treatment for breast cancer, preclinical study

[News]

Recent clinical trials have indicated that immune checkpoint blockade (ICB) therapy, which is designed to unleash a patient's immune system to attack cancer, has been revolutionary in its implications for breast cancer treatment, especially for its potential to treat patients with triple negative breast cancer.

More... (https://www.news-medical.net/news/20190908/Age-affects-efficacy-of-immunotherapy-treatment-for-breast-cancer-preclinical-study-reveals.aspx)